Study to test earlier treatment of COVID-19
A study is now enrolling participants to determine whether a treatment combining a low dose of hydroxychloroquine and azithromycin can prevent hospitalization and death in people with COVID-19.
Dr. Ann Collier, professor of medicine, Division of Allergy and Infectious Diseases at the University of Washington School of Medicine, explains the national study is looking to enroll 2,000 patients at sites across the country. This research project is a separate from another hydroxychloroquine clinical study at UW Medicine, but the results will complement each other.
To enroll, call or text 206.773.7129 or email email@example.com.